D. Russell-Jones

发表

IGF-I treatment in adults with type 1 diabetes: effects on glucose and protein metabolism in the fasting state and during a hyperinsulinemic-euglycemic amino acid clamp.

R. Hovorka, P. Carroll, I. Gowrie, 2000, Diabetes.

rhIGF-I Administration Reduces Insulin Requirements, Decreases Growth Hormone Secretion, and Improves the Lipid Profile in Adults With IDDM

D. Dunger, P. Carroll, P. Sönksen, 1997, Diabetes.

Effects of high-dose growth hormone on glucose and glycerol metabolism at rest and during exercise in endurance-trained athletes.

A. Umpleby, P. Sönksen, P. Croos, 2006, The Journal of clinical endocrinology and metabolism.

Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programme

B. Zinman, J. Buse, X. Pi-Sunyer, 2013, Diabetes, obesity & metabolism.

The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1–5 studies

L. Blonde, D. Russell-Jones, 2009, Diabetes, obesity & metabolism.

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

A. Vaag, R. Simó, N. Lalic, 2009, Diabetologia.

Insulin detemir, does a new century bring a better basal insulin?

D. Russell-Jones, S. Hordern, S. V. M. Hordern, 2005, International journal of clinical practice.

Miscoding, misclassification and misdiagnosis of diabetes in primary care

S. de Lusignan, K. Khunti, D. Russell-Jones, 2012, Diabetic medicine : a journal of the British Diabetic Association.

Sudden infant death in history and literature.

D. Russell-Jones, 1985, Archives of disease in childhood.

Growth hormone (GH) replacement therapy reduces serum sialic acid concentrations in adults with GH‐deficiency: a double‐blind placebo‐controlled study

P. Sönksen, E. Christ, D. Russell-Jones, 1999, Clinical endocrinology.

The effects of two doses of replacement growth hormone on the biochemical, body composition and psychological profiles of growth hormone-deficient adults.

P. Carroll, P. Sönksen, D. Russell-Jones, 1997, European journal of endocrinology.

Cerebral metabolism and growth hormone replacement in adults

Peter H. Sönksen, Paul Marsden, P. Marsden, 1998 .

Does GH replacement therapy in adult GH-deficient patients result in recurrence or increase in size of pituitary tumours?

D. Russell-Jones, P. Sonksen, A. Hatrick, 2002, European journal of endocrinology.

Effects of growth hormone (GH) replacement therapy on very low density lipoprotein apolipoprotein B100 kinetics in patients with adult GH deficiency: a stable isotope study.

A. Umpleby, P. Sönksen, E. Christ, 1999, The Journal of clinical endocrinology and metabolism.

The importance of growth hormone in the regulation of erythropoiesis, red cell mass, and plasma volume in adults with growth hormone deficiency.

P. Sönksen, E. Christ, D. Russell-Jones, 1997, The Journal of clinical endocrinology and metabolism.

Efficacy of increased resistant starch consumption in human type 2 diabetes

Jimmy D Bell, Elizabeth Louise Thomas, D. Russell-Jones, 2014, Endocrine connections.

Efficacy and safety of fast‐acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52‐week, randomized, treat‐to‐target, phase III trial

C. Mathieu, B. Bode, E. Franek, 2018, Diabetes, obesity & metabolism.

Insulin-like growth factor-I and diabetes. A review.

A. Umpleby, D. Russell-Jones, H. Simpson, 1998, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Pilots flying with insulin‐treated diabetes

Ewan J Hutchison, D. Russell-Jones, Graham A Roberts, 2021, Diabetes, obesity & metabolism.

Effect of subcutaneous insulin detemir on glucose flux and lipolysis during hyperglycaemia in people with type 1 diabetes

F. Shojaee-Moradie, N. Jackson, A. Umpleby, 2015, Diabetes, obesity & metabolism.

Hepatoselectivity and the evolution of insulin

D. Russell-Jones, R. Jones, R. Herring, 2014, Diabetes, obesity & metabolism.

Simultaneous Cushing's disease and tuberous sclerosis; a potential role for TSC in pituitary ontogeny

P. Carroll, D. Russell-Jones, S. Tigas, 2005, Clinical endocrinology.

Effects of low-dose recombinant human insulin-like growth factor-I on insulin sensitivity, growth hormone and glucagon levels in young adults with insulin-dependent diabetes mellitus.

D. Dunger, C. Acerini, A. Umpleby, 1998, Metabolism: clinical and experimental.

The hormonal control of protein metabolism.

A. Umpleby, D. Russell-Jones, 1996, Bailliere's clinical endocrinology and metabolism.

The Effects of Growth Hormone on Glucose & Protein Metabolism

A. Umpleby, D. Russell-Jones, 1999 .

The effect of growth hormone on pituitary tumour growth

D. Russell-Jones, R. Herring, 2010, Current opinion in endocrinology, diabetes, and obesity.

A potential diagnostic problem on the ICU: Euglycaemic diabetic Ketoacidosis associated with SGLT2 inhibition.

L. Forni, D. Russell-Jones, Alexander Sarnowski, 2019, Journal of critical care.

The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society The Effects of 10 Years of Recombinant Human Growth Hormone (GH) in Adult GH-Deficient Patients

T. Spinks, K. Burnand, P. Sönksen, 2022 .

An Evaluation of the Safety of Pilots With Insulin-Treated Diabetes in Europe Flying Commercial and Noncommercial Aircraft

Ewan J Hutchison, S. Heller, B. Frier, 2020, Diabetes Care.

Insulin-like growth factor I has a direct effect on glucose and protein metabolism, but no effect on lipid metabolism in type 1 diabetes.

D. Dunger, Richard H. Jones, F. Shojaee-Moradie, 2004, The Journal of clinical endocrinology and metabolism.

Insulin therapy in diabetes and cancer risk: Current understanding and implications for future study

S. Gough, J. Tuomilehto, B. Hansen, 2011, Advances in therapy.

Insulin X10 revisited: a super-mitogenic insulin analogue

B. Hansen, D. Russell-Jones, P. Kurtzhals, 2011, Diabetologia.

Insulin degludec results in lower rates of nocturnal hypoglycaemia and fasting plasma glucose vs. insulin glargine: A meta-analysis of seven clinical trials.

S. Del Prato, D. Russell-Jones, M. Gall, 2015, Nutrition, metabolism, and cardiovascular diseases : NMCD.

A surrogate measure of whole body leucine transport across the cell membrane.

R. Hovorka, P. Carroll, I. Gowrie, 1999, American journal of physiology. Endocrinology and metabolism.

The effects of growth hormone on protein metabolism in adult growth hormone deficient patients

Richard H. Jones, A. Umpleby, P. Sönksen, 1993, Clinical endocrinology.

Contrasting insulin sensitivity of endogenous glucose production rate in subjects with hepatocyte nuclear factor-1beta and -1alpha mutations.

A. Hattersley, F. Shojaee-Moradie, D. Russell-Jones, 2006, Diabetes.

Blood Glucose and Bodyweight in Type 2 Diabetes – Are These Compatible Treatment Targets?

D. Russell-Jones, 2008 .

Investigating the Association Between Baseline Characteristics (HbA1c and Body Mass Index) and Clinical Outcomes of Fast-Acting Insulin Aspart in People with Diabetes: A Post Hoc Analysis

C. Dethlefsen, H. Rodbard, S. Heller, 2018, Diabetes Therapy.

Normal VLDL metabolism despite altered lipoprotein composition in type 1 diabetes mellitus

P. Carroll, A. Umpleby, P. Sönksen, 2001, Clinical endocrinology.

Lixisenatide Reduces Chylomicron Triacylglycerol by Increased Clearance

R. Hovorka, F. Shojaee-Moradie, N. Jackson, 2018, The Journal of clinical endocrinology and metabolism.

A comparison of the effects of IGF‐I and insulin on glucose metabolism, fat metabolism and the cardiovascular system in normal human volunteers

T. R. Hennessy, Richard H. Jones, F. Shojaee-Moradie, 1995, European journal of clinical investigation.

Molecular, pharmacological and clinical aspects of liraglutide, a once-daily human GLP-1 analogue

D. Russell-Jones, 2009, Molecular and Cellular Endocrinology.

Oral treatment with an antioxidant (raxofelast) reduces oxidative stress and improves endothelial function in men with Type II diabetes

J. Ritter, P. Chowienczyk, E. Änggård, 2000, Diabetologia.

Effect of growth hormone treatment on postprandial protein metabolism in growth hormone-deficient adults.

R. Hovorka, N. Jackson, A. Umpleby, 1998, American journal of physiology. Endocrinology and metabolism.

The effect of recombinant human growth hormone on glucose and leucine metabolism in Cushing's syndrome.

P. Carroll, N. Jackson, P. Sönksen, 1997, The Journal of clinical endocrinology and metabolism.

Protein anabolic action of insulin, growth hormone and insulin-like growth factor I.

D. Russell-Jones, M. Umpleby, 1996, European journal of endocrinology.

Significantly Better Glycemic Control and Weight Reduction with Liraglutide, a Once-daily Human GLP-1 Analog, Compared with Insulin Glargine: All as Add-on to Metformin and a Sulfonylurea in Type 2 Diabetes.

A. Vaag, R. Simó, N. Lalic, 2008 .

Discovery of insulin 100 years on

D. Russell-Jones, Zosanglura Bawlchhim, 2022, Postgraduate medical journal.

Recombinant human insulin‐like growth factor‐I (rhIGF‐I) therapy in adults with type 1 diabetes mellitus: effects on IGFs, IGF‐binding proteins, glucose levels and insulin treatment

P. Carroll, P. Sönksen, D. Russell-Jones, 1998, Clinical endocrinology.

Pegvisomant improves insulin sensitivity and reduces overnight free fatty acid concentrations in patients with acromegaly.

D. Russell-Jones, A. Umpleby, P. Trainer, 2009, The Journal of clinical endocrinology and metabolism.

The mechanism of non‐islet cell hypoglycaemia caused by tumour‐produced IGF‐II

F. Shojaee-Moradie, D. Russell-Jones, A. Umpleby, 2007, Clinical endocrinology.

Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes

F. Shojaee-Moradie, N. Jackson, M. Davies, 2020, Diabetes Care.

Intraperitoneal insulin is more potent than subcutaneous insulin at restoring hepatic insulin-like growth factor-I mRNA levels in the diabetic rat: a functional role for the portal vascular link.

P. Sönksen, M. Rattray, D. Russell-Jones, 1992, Journal of molecular endocrinology.

Glutamine supplementation and GH/IGF-I treatment in critically ill patients: effects on glutamine metabolism and protein balance.

P. Carroll, N. Jackson, A. Umpleby, 2002, Nutrition.

The Metabolic Effects of Growth Hormone (GH)

D. Russell-Jones, 1994 .

Effect of growth hormone (GH) on glycerol and free fatty acid metabolism during exhaustive exercise in GH-deficient adults

A. Umpleby, P. Sönksen, S. Bowes, 2003 .

The effect of growth hormone (GH) replacement therapy in adult patients with type 1 diabetes mellitus and GH deficiency

E. Christ, D. Russell-Jones, E. Kohner, 2003, Clinical endocrinology.

Efficacy of iGlarLixi in adults with type 2 diabetes inadequately controlled (glycated haemoglobin ≥8%, ≥64 mmol/mol) on two oral antidiabetes drugs: Post hoc analysis of the LixiLan‐O randomized trial

J. Rosenstock, M. Davies, D. Russell-Jones, 2021, Diabetes, obesity & metabolism.

Glycaemic benefit of iGlarLixi in insulin‐naive type 2 diabetes patients with high HbA1c or those with inadequate glycaemic control on two oral antihyperglycaemic drugs in the LixiLan‐O randomized trial

M. Davies, T. Barber, D. Russell-Jones, 2019, Diabetes, obesity & metabolism.

Is insulin the most effective injectable antihyperglycaemic therapy?

J. Buse, A. Peters, D. Russell-Jones, 2015, Diabetes, obesity & metabolism.

Rosiglitazone or pioglitazone in type 2 diabetes?

D. Russell-Jones, C. Vries, 2009, BMJ : British Medical Journal.

Effect of IGF-I therapy on VLDL apolipoprotein B100 metabolism in type 1 diabetes mellitus.

P. Carroll, A. Umpleby, P. Sönksen, 2002, American journal of physiology. Endocrinology and metabolism.

Effect of growth hormone treatment on postprandial protein metabolism in growth hormone-deficient adults

R. Hovorka, N. Jackson, A. Umpleby, 1998 .

SGLT inhibition and euglycaemic diabetic ketoacidosis.

D. Russell-Jones, E. Abrol, R. Herring, 2015, The lancet. Diabetes & endocrinology.

Insulin and managing weight

D. Russell-Jones, S. Zachariah, 2008 .

Dyslipidaemia in Adult Growth Hormone (GH) Deficiency and the Effect of GH Replacement Therapy: A Review

E. Christ, D. Russell-Jones, M. Cummings, 1998, Trends in Endocrinology & Metabolism.

Short Report: Treatment Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal–bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN® Basal–Bolus Type 1): 2-year results of a randomized clinical trial

E. Renard, S. Garg, S. Heller, 2013, Diabetic medicine : a journal of the British Diabetic Association.

The importance of growth hormone in the regulation of erythropoiesis, red cell mass, and plasma volume in adults with growth hormone deficiency.

P. Sönksen, E. Christ, D. Russell-Jones, 1997, The Journal of clinical endocrinology and metabolism.

Octreotide induced prolongation of colonic transit increases faecal anaerobic bacteria, bile acid metabolising enzymes, and serum deoxycholic acid in patients with acromegaly

M. Veysey, D. Russell-Jones, J. Wass, 2005, Gut.

Response to Comment on Herring et al. Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes. Diabetes Care 2020;43:2128–2136

F. Shojaee-Moradie, N. Jackson, M. Davies, 2021, Diabetes Care.

High dose growth hormone exerts an anabolic effect at rest and during exercise in endurance-trained athletes.

A. Umpleby, P. Sönksen, P. Croos, 2003, The Journal of clinical endocrinology and metabolism.

Intraperitoneal Insulin Affects Insulin-Like Growth Factor Binding Protein-1 in a Well-Controlled Type I Diabetic Patient

E. Lehmann, P. Sönksen, D. Russell-Jones, 1993, Diabetes Care.

Serum Sialic Acid, a Possible Cardiovascular Risk Factor is Not Increased in Fijian Melanesians with Impaired Glucose Tolerance or Impaired Fasting Glucose

D. Russell-Jones, P. Lumb, M. Crook, 2002, Annals of clinical biochemistry.

Intrapulmonary shunt measured by bedside pulse oximetry predicts worse outcomes in severe COVID-19

D. Russell-Jones, T. Dassios, E. Russell-Jones, 2020, European Respiratory Journal.

Fatty acid flux and oxidation are increased by rimonabant in obese women.

Jimmy D Bell, Elizabeth Louise Thomas, F. Shojaee-Moradie, 2012, Metabolism: clinical and experimental.

Clinical experience in identical twins discordant for adult-onset growth hormone deficiency.

P. Sönksen, D. Russell-Jones, H. Simpson, 1999, Journal of endocrinological investigation.

The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient patients

G. Watts, P. Sönksen, R. Naoumova, 1994, Clinical endocrinology.

Simulation of IGF-I pharmacokinetics after infusion of recombinant IGF-I in human subjects.

P. Sönksen, M. Boroujerdi, D. Russell-Jones, 1997, The American journal of physiology.

The consequences of growth hormone deficiency in adulthood, and the effects of growth hormone replacement.

P. Carroll, P. Sönksen, E. Christ, 1997, Schweizerische medizinische Wochenschrift.

Growth hormone and diabetes mellitus. A review of sixty-three years of medical research and a glimpse into the future?

P. Sönksen, D. Russell-Jones, R. Jones, 1993, Hormone research.

SGLT2 inhibitors in Type 1 diabetes: is this the future?

D. Russell-Jones, R. Herring, 2018, Diabetic medicine : a journal of the British Diabetic Association.

Effects of growth hormone (GH) replacement therapy on low-density lipoprotein apolipoprotein B100 kinetics in adult patients with GH deficiency: a stable isotope study.

N. Jackson, A. Umpleby, P. Sönksen, 2004, The Journal of clinical endocrinology and metabolism.

Can an interprofessional education tool improve healthcare professional confidence, knowledge and quality of inpatient diabetes care: a pilot study?

D. Russell-Jones, R. Herring, C. Pengilley, 2013, Diabetic medicine : a journal of the British Diabetic Association.

Intrapulmonary shunting is a key contributor to hypoxia in COVID-19: An update on the pathophysiology

D. Russell-Jones, T. Dassios, E. Russell-Jones, 2022, PloS one.

Exercise-induced GH secretion is enhanced by the oral ingestion of melatonin in healthy adult male subjects.

M. Forsling, J. Wallace, R. Cuneo, 1999, European journal of endocrinology.

A UK Civil Aviation Authority protocol to allow pilots with insulin-treated diabetes to fly commercial aircraft.

S. Heller, B. Frier, D. Russell-Jones, 2017, The lancet. Diabetes & endocrinology.

Management of raised glucose, a clinical decision tool to reduce length of stay of patients with hyperglycaemia

D. Russell-Jones, S. Hordern, J. Wright, 2013, Diabetic medicine : a journal of the British Diabetic Association.

Low-density lipoprotein apolipoprotein B100 turnover in hypopituitary patients with GH deficiency: a stable isotope study.

N. Jackson, A. Umpleby, P. Sönksen, 2006, European journal of endocrinology.

Insulin detemir: improving the predictability of glycaemic control

D. Russell-Jones, 2004, International Journal of Obesity.

A review of the NG17 recommendations for the use of basal insulin in type 1 diabetes

E. Wilmot, M. Fisher, D. Russell-Jones, 2019, Diabetic medicine : a journal of the British Diabetic Association.

HbA1c and hypoglycaemia outcomes for people with type 1 diabetes due to the introduction of a single-day structured education programme and flash glucose monitoring

D. Russell-Jones, R. Herring, K. Mackie, 2021 .

The frequency and consequences of head injury in epileptic seizures.

S. Shorvon, D. Russell-Jones, D. Russell‐Jones, 1989, Journal of neurology, neurosurgery, and psychiatry.

Hormone abuse in sport.

D. Russell-Jones, 1999, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

100 years of physiology, discrimination and wonder

D. Russell-Jones, R. Herring, 2021, Diabetic medicine : a journal of the British Diabetic Association.

Low-density lipoprotein apolipoprotein B 100 turnover in hypopituitary patients with GH deficiency : a stable isotope study

N. Jackson, A. Umpleby, P. Sönksen, 2006 .

Short-term safety and efficacy of human GH replacement therapy in 595 adults with GH deficiency: a comparison of two dosage algorithms.

S. Ezzat, P. Sönksen, A. Luger, 2002, The Journal of clinical endocrinology and metabolism.

Abnormalities of very low density lipoprotein apolipoprotein B-100 metabolism contribute to the dyslipidaemia of adult growth hormone deficiency.

A. Umpleby, P. Sönksen, E. Christ, 1997, The Journal of clinical endocrinology and metabolism.

Emergency management of diabetes and hypoglycaemia

D. Russell-Jones, R. Lawrenson, A. Brackenridge, 2006, Emergency Medicine Journal.

A comparison of insulin detemir and neutral protamine Hagedorn (isophane) insulin in the treatment of diabetes: a systematic review

B. Frier, T. Heise, D. Russell-Jones, 2013, Diabetes, obesity & metabolism.

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

E. Renard, S. Garg, S. Heller, 2012, The Lancet.

A surrogate measure of whole body leucine transport across the cell membrane.

R. Hovorka, P. Carroll, I. Gowrie, 1999, The American journal of physiology.

Basal insulin peglispro versus insulin glargine in insulin‐naïve type 2 diabetes: IMAGINE 2 randomized trial

J. Bue-Valleskey, T. Bailey, M. Davies, 2016, Diabetes, obesity & metabolism.

Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen.

D. Russell-Jones, R. Simpson, J. Bolinder, 2004, Clinical therapeutics.

Vasculitis complicating cystic fibrosis.

M. Hodson, D. Russell-Jones, E. Sheffield, 1989, The Quarterly journal of medicine.

Central hypoventilation in a seven year old child following pertussis treated with negative pressure ventilation.

D. Treacher, D. Russell-Jones, G. Spencer, 1989, Postgraduate medical journal.

Inhibitory effects of low-density lipoproteins from men with type II diabetes on endothelium-dependent relaxation.

P. Chowienczyk, J. Ritter, P. Chowienczyk, 2000, Journal of the American College of Cardiology.

Psychological effects of withdrawal of growth hormone therapy from adults with growth hormone deficiency

P. Sönksen, D. Russell-Jones, J. Gibney, 2003, Clinical endocrinology.

Skin problem in the diabetic clinic

D. Russell-Jones, F. Ahmed, D. Sennik, 2011 .

Exenatide, a GLP-1 agonist in the treatment of Type 2 diabetes

D. Russell-Jones, F. Ahmed, D. Sennik, 2012, Expert review of endocrinology & metabolism.

Insulin-sensitizing effects on muscle and adipose tissue after dietary fiber intake in men and women with metabolic syndrome.

F. Shojaee-Moradie, H. Vidal, D. Russell-Jones, 2012, The Journal of clinical endocrinology and metabolism.

The metabolic consequences of critical illness: acute effects on glutamine and protein metabolism.

P. Carroll, N. Jackson, A. Umpleby, 1999, American journal of physiology. Endocrinology and metabolism.

Combined growth hormone/insulin-like growth factor I in addition to glutamine-supplemented TPN results in net protein anabolism in critical illness.

P. Carroll, N. Jackson, A. Umpleby, 2004, American journal of physiology. Endocrinology and metabolism.

Effects of glutamine supplementation, GH, and IGF-I on glutamine metabolism in critically ill patients.

P. Carroll, N. Jackson, A. Umpleby, 2000, American journal of physiology. Endocrinology and metabolism.

Use of a leucine clamp to demonstrate that IGF-I actively stimulates protein synthesis in normal humans.

T. R. Hennessy, F. Shojaee-Moradie, N. Jackson, 1994, The American journal of physiology.

Fecal Enterobacteriales enrichment is associated with increased in vivo intestinal permeability in humans

U. Ijaz, Patrice D Cani, D. Russell-Jones, 2018, Physiological reports.

Contrasting Insulin Sensitivity of Endogenous Glucose Production Rate in Subjects With Hepatocyte Nuclear Factor-1β and -1α Mutations

A. Hattersley, F. Shojaee-Moradie, D. Russell-Jones, 2006 .

The safety and tolerability of GLP‐1 receptor agonists in the treatment of type‐2 diabetes

D. Russell-Jones, 2010, International journal of clinical practice.

The role of incretin‐based therapies in the management of type 2 diabetes

D. Russell-Jones, 2009 .

Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension

C. Mathieu, E. Franek, D. Russell-Jones, 2013, The Journal of clinical endocrinology and metabolism.

A prospective, randomized pilot study evaluating the effects of metformin and lifestyle intervention on patients with prostate cancer receiving androgen deprivation therapy

R. Laing, S. Langley, D. Russell-Jones, 2012, BJU international.

Growth Hormone and Diabetes mellitus

P. Sönksen, D. Russell-Jones, R. Jones, 1993 .

Insulin analogues and cancer risk: cause for concern or cause célèbre?

M. Pollak, D. Russell-Jones, David Russell-Jones, 2010, International journal of clinical practice.

Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes: a randomized clinical trial.

P. Home, M. Landin-Olsson, D. Russell-Jones, 2004, Diabetes care.

Management of type 2 diabetes: the current situation and key opportunities to improve care in the UK

K. Khunti, D. Russell-Jones, S. Bain, 2016, Diabetes, obesity & metabolism.

Effects of three weeks of mild sleep restriction implemented in the home environment on multiple metabolic and endocrine markers in healthy young men.

D. Dijk, A. Umpleby, D. Russell-Jones, 2013, Metabolism: clinical and experimental.

Evaluation of two health status measures in adults with growth hormone deficiency

P. Sönksen, D. Russell-Jones, J. Gibney, 2003, Clinical endocrinology.

Efficacy and Safety of Exenatide Once Weekly Versus Metformin, Pioglitazone, and Sitagliptin Used as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)

M. Hanefeld, R. Cuddihy, Ajay Mahaputra Kumar, 2012, Diabetes Care.

Insulin‐associated weight gain in diabetes – causes, effects and coping strategies

D. Russell-Jones, Rehman Khan, 2007, Diabetes, obesity & metabolism.

Fast-Acting Insulin Aspart Improves Glycemic Control in Basal-Bolus Treatment for Type 1 Diabetes: Results of a 26-Week Multicenter, Active-Controlled, Treat-to-Target, Randomized, Parallel-Group Trial (onset 1)

S. Heller, C. Mathieu, R. Bergenstal, 2017, Diabetes Care.

Insulin analogues: an example of applied medical science

D. Russell-Jones, B. Sheldon, J. Wright, 2009, Diabetes, obesity & metabolism.

Identification of barriers to insulin therapy and approaches to overcoming them

K. Khunti, F. Pouwer, D. Russell-Jones, 2017, Diabetes, obesity & metabolism.

Take Control: A randomized trial evaluating the efficacy and safety of self‐ versus physician‐managed titration of insulin glargine 300 U/mL in patients with uncontrolled type 2 diabetes

M. Davies, E. Delgado, G. Dimitriadis, 2019, Diabetes, obesity & metabolism.

Comparison of the effects on glucose and lipid metabolism of equipotent doses of insulin detemir and NPH insulin with a 16-h euglycaemic clamp

F. Shojaee-Moradie, A. Umpleby, D. Russell-Jones, 2005, Diabetologia.

Rationale and design of the phase 3a development programme (ONWARDS 1–6 trials) investigating once‐weekly insulin icodec in diabetes

J. Rosenstock, K. Begtrup, D. Russell-Jones, 2022, Diabetes, obesity & metabolism.

Leveraging advances in diabetes technologies in primary care: a narrative review

Aaron M. King, B. Bode, L. Billings, 2021, Annals of medicine.

Serum sialic acid, a reputed cardiovascular risk factor, is related to serum leptin concentrations in Fijians.

D. Russell-Jones, P. Lumb, M. Crook, 2003, Clinica chimica acta; international journal of clinical chemistry.

Insulin Detemir Reduces Weight Gain as a Result of Reduced Food Intake in Patients With Type 1 Diabetes

Richard H. Jones, F. Shojaee-Moradie, N. Jackson, 2011, Diabetes Care.

Differential effects of insulin detemir and neutral protamine Hagedorn (NPH) insulin on hepatic glucose production and peripheral glucose uptake during hypoglycaemia in type 1 diabetes

D. Russell-Jones, R. Jones, A. Umpleby, 2009, Diabetologia.

Insulin detemir and basal insulin therapy.

D. Russell-Jones, 2007, Endocrinology and metabolism clinics of North America.

Weight‐sparing effect of insulin detemir: a consequence of central nervous system‐mediated reduced energy intake?

T. Danne, J. Vasselli, K. Hermansen, 2015, Diabetes, obesity & metabolism.

Characteristics and outcomes of patients with COVID-19 at a district general hospital in Surrey, UK.

D. Russell-Jones, S. Mathew, M. Cox, 2020, Clinical medicine.

Central hypoventilation inaseven year oldchild following pertussis treated withnegative pressure ventilation

D. Treacher, D. Russell-Jones, H. Lenicker, 1989 .

The metabolic consequences of critical illness: acute effects on glutamine and protein metabolism.

P. Carroll, N. Jackson, A. Umpleby, 1999, The American journal of physiology.

Computer assisted learning is an effective way of teaching endocrinology

P. Sönksen, R. Holt, D. Russell-Jones, 2001, Clinical endocrinology.

Efficacy and safety of insulin degludec three times a week versus insulin glargine once a day in insulin-naive patients with type 2 diabetes: results of two phase 3, 26 week, randomised, open-label, treat-to-target, non-inferiority trials.

Lawrence A Leiter, B. Zinman, J. DeVries, 2013, The lancet. Diabetes & endocrinology.

Does diabetes put you at risk of tetanus

D. Russell-Jones, H. Soulsby, 2010 .

Current developments in the treatment of diabetes: the incretin therapies

D. Russell-Jones, 2010 .

Growth hormone and sport: abuse, potential benefits, and difficulties in detection.

D. Russell-Jones, M. Healy, 1997, British journal of sports medicine.

Lessons for modern insulin development

D. Russell-Jones, R. Herring, D. D. L. Russell‐Jones, 2018, Diabetic medicine : a journal of the British Diabetic Association.

Projected long‐term outcomes in patients with type 1 diabetes treated with fast‐acting insulin aspart vs conventional insulin aspart in the UK setting

S. Heller, D. Russell-Jones, W. Valentine, 2017, Diabetes, obesity & metabolism.

Galacto-Oligosaccharide has no Effect on Glucose Tolerance, inflammatory Markers or Intestinal Permeability in well-controlled Type 2 Diabetes

U. Ijaz, Patrice D Cani, G. Gibson, 2016, Proceedings of the Nutrition Society.

Recent advances in incretin‐based therapies

S. Gough, D. Russell-Jones, 2012, Clinical endocrinology.

Psychometric properties of two measures of psychological well-being in adult growth hormone deficiency

Clare Bradley, P. Sönksen, D. Russell-Jones, 2006, Health and quality of life outcomes.

Insulin Degludec Allows for Flexible Daily Dosing in Type 1 Diabetes, Providing Equal Glycemic Control with Less Nocturnal Hypoglycemia than Insulin Glargine Over 52 Weeks

C. Mathieu, E. Franek, D. Russell-Jones, 2012 .

EXERCISE TRAINING ALTERS VLDL TG AND APOB METABOLISM IN MEN WITH NON-ALCOHOLIC LIVER DISEASE (NAFLD)

Jimmy D Bell, G. Kemp, F. Shojaee-Moradie, 2015 .

Effect of subcutaneous insulin detemir on glucose flux, lipolysis and electroencephalography in type 1 diabetes

F. Shojaee-Moradie, N. Jackson, A. Umpleby, 2015, Diabetes, obesity & metabolism.

Insulin-like growth factor binding protein-1 levels in diabetic proliferative retinopathy.

P. Sönksen, D. Russell-Jones, K. Hopkins, 1993, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Preliminary development of the new individualized HDQoL questionnaire measuring quality of life in adult hypopituitarism.

P. Sönksen, D. Russell-Jones, J. Gibney, 2006, Journal of evaluation in clinical practice.

Protein metabolism in growth hormone deficiency, and effects of growth hormone replacement therapy.

A. Umpleby, P. Sönksen, S. Bowes, 1993, Acta Endocrinologica.

Management of type 2 diabetes: the current situation and key opportunities to improve care in the UK.

K. Khunti, D. Russell-Jones, S. Bain, 2016 .

USA joins Canada, UK, Ireland and Austria in allowing people with insulin‐treated diabetes to fly commercial aircraft

B. Frier, D. Russell-Jones, K. Shaw, 2020, Diabetic medicine : a journal of the British Diabetic Association.

Blood glucose monitoring by insulin‐treated pilots of commercial and private aircraft: An analysis of out‐of‐range values

Ewan J Hutchison, S. Heller, B. Frier, 2021, Diabetes, obesity & metabolism.

The use of routine blood tests to assist the diagnosis of COVID-19 in symptomatic hospitalized patients

Dulani Woods, D. Russell-Jones, M. Stacey, 2021, Annals of clinical biochemistry.

Effects of rosiglitazone and pioglitazone on lipoprotein metabolism in patients with type 2 diabetes

R. Hovorka, F. Shojaee-Moradie, N. Jackson, 2012 .

E. Renard, S. Garg, S. Heller, 2012, The Lancet.

Insulin degludec results in lower rates of nocturnal hypoglycaemia and fasting plasma glucose vs. insulin glargine: A meta-analysis of seven clinical trials.

D. Russell-Jones, M. Gall, M. Diamant, 2015, Nutrition, metabolism, and cardiovascular diseases : NMCD.

CONTINUOUS GLUCOSE MONITORING BY INSULIN-TREATED PILOTS FLYING COMMERCIAL AIRCRAFT WITHIN THE ARA.MED.330 DIABETES PROTOCOL: A PRELIMINARY FEASIBILITY STUDY.

Ewan J Hutchison, B. Frier, F. Shojaee-Moradie, 2023, Diabetes technology & therapeutics.

Assisted feeding for elderly inpatients.

John Jerrim, D. Russell-Jones, A. Appleton, 2013, Clinical medicine (London).

Molecular, pharmacological and clinical aspects of liraglutide, a once-daily human GLP-1 analogue

D. Russell-Jones, 2009, Molecular and Cellular Endocrinology.

Ovarian hyperstimulation from ectopic hypersecretion of follicle stimulating hormone

N. Pellegata, A. Miras, P. Xekouki, 2015, The Lancet.

The efficacy and tolerability of chewable carbamazepine compared to conventional carbamazepine in patients with epilepsy

J. W. A. S. Sander, S. Shorvon, P. Patsalos, 1990, Epilepsy Research.

The SGLT2 Inhibitor Dapagliflozin Increases the Oxidation of Ingested Fatty Acids to Ketones in Type 2 Diabetes.

F. Shojaee-Moradie, N. Jackson, B. Middleton, 2022, Diabetes care.

Pegvisomant improves insulin sensitivity and reduces overnight free fatty acid concentrations in patients with acromegaly.

D. Russell-Jones, A. Umpleby, P. Trainer, 2009, The Journal of clinical endocrinology and metabolism.

Response to Comment on Russell-Jones et al. Diabetes Care 2017;40:943–950. Comment on Bowering et al. Diabetes Care 2017;40:951–957

B. Bode, D. Russell-Jones, K. Bowering, 2018, Diabetes Care.

SGLT inhibition and euglycaemic diabetic ketoacidosis.

D. Russell-Jones, E. Abrol, R. Herring, 2015, The lancet. Diabetes & endocrinology.